To Assess the Relative Bioavailability (BA) of TRIUMEQ® and Dolutegravir and Lamivudine (DTG/3TC) Pediatric Dispersible Tablet Formulations in Healthy Volunteers

NCT03441984 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Treatment A
DRUG: Treatment B
DRUG: Treatment C
DRUG: Treatment D
DRUG: Treatment E
DRUG: Treatment F

Sponsor

ViiV Healthcare

Collaborators

[object Object]
[object Object]